Puig Shares Struggle to Make Headway After Blockbuster Spain IPO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 03 2024
0mins
Should l Buy IPAR?
Source: Bloomberg
- Puig's IPO Debut: Puig, a Spanish beauty and fragrance group, had a muted trading debut as a public company, with shares trading at €24.50 each in line with its €2.6 billion IPO pricing.
- Market Response: The flat trading of Puig's shares on the first day raised concerns about value for investors, despite strong demand during the offering.
- Comparison to Other IPOs: Puig's debut contrasted with the successful starts of other companies like CVC and Galderma, which surged over 20% in their initial trading sessions.
- European IPO Market: Despite Puig's subdued debut, the European IPO market is showing signs of recovery, with companies raising about $12 billion in the year so far.
- Ownership and Future Plans: The Puig family retains over 90% of voting rights post-IPO, and the company plans to use proceeds for refinancing, debt repayment, and future investments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IPAR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IPAR
Wall Street analysts forecast IPAR stock price to rise
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 94.030
Low
85.00
Averages
108.60
High
125.00
Current: 94.030
Low
85.00
Averages
108.60
High
125.00
About IPAR
Interparfums, Inc. produces and distributes a range of fragrance and fragrance related products. It operates through two segments: European based operations and United States based operations. It produces and distributes its fragrance products under license agreements with brand owners, and fragrance product sales through its European based operations segment. It has a portfolio of brands including Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas, Goutal, and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world. Its brand fragrance products are also produced and marketed through its United States based operations. These fragrance products are sold under trademarks owned by the Company or pursuant to license or other agreements with the owners of brands, which include Abercrombie & Fitch, Anna Sui, DKNY, Emanuel Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta and Roberto Cavalli.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
INTERPARFUMS CEO: NO TALKS UNDERWAY WITH COTY REGARDING ACQUISITION OF BOSS AND BURBERRY LICENSES
- Current Discussions: There are no ongoing discussions regarding Coty acquiring Boss or Burberry licenses.
- CEO Statement: The CEO of Interparfums has confirmed the lack of negotiations or talks on these potential acquisitions.
See More
Inter Parfums CEO Sells 20,000 Shares Indirectly
- Transaction Overview: On April 2, 2026, Inter Parfums CEO Jean Madar indirectly sold 20,000 shares of common stock for approximately $1.82 million, indicating stability in his holding structure with indirect ownership still exceeding 7 million shares.
- Impact on Ownership Proportion: This indirect sale accounted for 0.28% of Madar's pre-transaction holdings, suggesting that his confidence in long-term ownership remains intact, with direct holdings unchanged at 10,500 shares post-sale.
- Market Environment Analysis: The shares were sold at $91.02 each, while the market close on April 2, 2026, was $90.61, reflecting that the sale occurred in a context where the company's stock has declined about 10% over the past year, indicating no pessimism about the company's outlook.
- Stable Business Performance: Inter Parfums achieved record net sales of $1.49 billion in 2025, up 2% year-over-year, and despite facing margin pressures and uneven regional demand, the company continues to generate consistent earnings and cash flow, demonstrating execution strength in a maturing growth phase.
See More
Inter Parfums CEO Sells Shares: Analysis
- Share Sale Details: Inter Parfums CEO Jean Madar sold 20,000 shares indirectly on April 2, 2026, for approximately $1.82 million, representing 0.28% of his indirect holdings, indicating routine portfolio management rather than a negative outlook on the company.
- Transaction Price Analysis: The sale price was $91.02 per share, while the post-transaction market close was $90.61, suggesting that despite a slight decline, overall market confidence in the company remains intact without signs of aggressive selling.
- Financial Performance Overview: Inter Parfums achieved record net sales of $1.49 billion in 2025, up 2% year-over-year, with diluted EPS of $5.24, although facing margin compression and a slight decline in operating income to $270 million, the company continues to demonstrate stable profitability.
- Market Outlook and Challenges: While global demand for prestige fragrances remains strong, management highlighted tariffs and increased promotional spending as ongoing headwinds, prompting investors to focus on the company's execution capabilities amid a maturing growth phase and uneven regional demand.
See More
Acme United Shares Rise 5%, Show Resilience Amid Challenges
- Stock Performance: Acme United's shares rose 5% to $46 in the last trading session, with impressive volume indicating strong market confidence, despite a 1% decline over the past four weeks.
- Earnings Expectations: The company is expected to report quarterly earnings of $0.55 per share, reflecting a 34.2% year-over-year increase, with revenues projected at $47.1 million, up 2.5% from the previous year, showcasing its stability in profitability and growth.
- Market Share Expansion: Acme United's ongoing expansion in first aid and medical products, coupled with the strategic acquisition of My Medic, enhances its competitive edge and positions it to capture additional market share while diversifying its revenue streams.
- Earnings Estimate Revision: Despite optimistic growth expectations, the consensus EPS estimate has been revised down by 1.8% over the last 30 days, indicating that negative trends in earnings revisions could hinder stock price appreciation, prompting investors to monitor future developments closely.
See More
Inter Parfums (IPAR) Q4 2025 Earnings Transcript
See More
Inter Parfums Declares $0.80 Quarterly Dividend, Consistent Yield
- Dividend Stability: Inter Parfums declares a quarterly dividend of $0.80 per share, maintaining this amount for five consecutive quarters, which demonstrates the company's stability and commitment to shareholders in the current economic environment.
- Earnings Beat: The company reported a GAAP EPS of $0.88, exceeding expectations by $0.09, indicating strong profitability and the ability to achieve growth despite facing near-term headwinds.
- Revenue Growth: Inter Parfums achieved revenue of $386.18 million, surpassing market expectations by $13.95 million, reflecting its robust performance in the fragrance market and effective market strategies.
- Dividend Yield: The forward yield of 3.11% provides investors with a stable return, enhancing the company's attractiveness in the capital markets.
See More
INTERPARFUMS CEO: NO TALKS UNDERWAY WITH COTY REGARDING ACQUISITION OF BOSS AND BURBERRY LICENSES
- Current Discussions: There are no ongoing discussions regarding Coty acquiring Boss or Burberry licenses.
- CEO Statement: The CEO of Interparfums has confirmed the lack of negotiations or talks on these potential acquisitions.
See More
Inter Parfums CEO Sells 20,000 Shares Indirectly
- Transaction Overview: On April 2, 2026, Inter Parfums CEO Jean Madar indirectly sold 20,000 shares of common stock for approximately $1.82 million, indicating stability in his holding structure with indirect ownership still exceeding 7 million shares.
- Impact on Ownership Proportion: This indirect sale accounted for 0.28% of Madar's pre-transaction holdings, suggesting that his confidence in long-term ownership remains intact, with direct holdings unchanged at 10,500 shares post-sale.
- Market Environment Analysis: The shares were sold at $91.02 each, while the market close on April 2, 2026, was $90.61, reflecting that the sale occurred in a context where the company's stock has declined about 10% over the past year, indicating no pessimism about the company's outlook.
- Stable Business Performance: Inter Parfums achieved record net sales of $1.49 billion in 2025, up 2% year-over-year, and despite facing margin pressures and uneven regional demand, the company continues to generate consistent earnings and cash flow, demonstrating execution strength in a maturing growth phase.
See More
Inter Parfums CEO Sells Shares: Analysis
- Share Sale Details: Inter Parfums CEO Jean Madar sold 20,000 shares indirectly on April 2, 2026, for approximately $1.82 million, representing 0.28% of his indirect holdings, indicating routine portfolio management rather than a negative outlook on the company.
- Transaction Price Analysis: The sale price was $91.02 per share, while the post-transaction market close was $90.61, suggesting that despite a slight decline, overall market confidence in the company remains intact without signs of aggressive selling.
- Financial Performance Overview: Inter Parfums achieved record net sales of $1.49 billion in 2025, up 2% year-over-year, with diluted EPS of $5.24, although facing margin compression and a slight decline in operating income to $270 million, the company continues to demonstrate stable profitability.
- Market Outlook and Challenges: While global demand for prestige fragrances remains strong, management highlighted tariffs and increased promotional spending as ongoing headwinds, prompting investors to focus on the company's execution capabilities amid a maturing growth phase and uneven regional demand.
See More
Acme United Shares Rise 5%, Show Resilience Amid Challenges
- Stock Performance: Acme United's shares rose 5% to $46 in the last trading session, with impressive volume indicating strong market confidence, despite a 1% decline over the past four weeks.
- Earnings Expectations: The company is expected to report quarterly earnings of $0.55 per share, reflecting a 34.2% year-over-year increase, with revenues projected at $47.1 million, up 2.5% from the previous year, showcasing its stability in profitability and growth.
- Market Share Expansion: Acme United's ongoing expansion in first aid and medical products, coupled with the strategic acquisition of My Medic, enhances its competitive edge and positions it to capture additional market share while diversifying its revenue streams.
- Earnings Estimate Revision: Despite optimistic growth expectations, the consensus EPS estimate has been revised down by 1.8% over the last 30 days, indicating that negative trends in earnings revisions could hinder stock price appreciation, prompting investors to monitor future developments closely.
See More
Inter Parfums (IPAR) Q4 2025 Earnings Transcript
See More
Inter Parfums Declares $0.80 Quarterly Dividend, Consistent Yield
- Dividend Stability: Inter Parfums declares a quarterly dividend of $0.80 per share, maintaining this amount for five consecutive quarters, which demonstrates the company's stability and commitment to shareholders in the current economic environment.
- Earnings Beat: The company reported a GAAP EPS of $0.88, exceeding expectations by $0.09, indicating strong profitability and the ability to achieve growth despite facing near-term headwinds.
- Revenue Growth: Inter Parfums achieved revenue of $386.18 million, surpassing market expectations by $13.95 million, reflecting its robust performance in the fragrance market and effective market strategies.
- Dividend Yield: The forward yield of 3.11% provides investors with a stable return, enhancing the company's attractiveness in the capital markets.
See More
